Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-14-004302
Filing Date
2014-03-17
Accepted
2014-03-17 08:39:41
Documents
15
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K furx20131231_10k.htm 10-K 2056725
2 EXHIBIT 21.1 ex21-1.htm EX-21 4599
3 EXHIBIT 23.1 ex23-1.htm EX-23 3199
4 EXHIBIT 31.1 ex31-1.htm EX-31 11990
5 EXHIBIT 31.2 ex31-2.htm EX-31 12035
6 EXHIBIT 32.1 ex32-1.htm EX-32 6532
7 EXHIBIT 32.2 ex32-2.htm EX-32 6466
14 furx20131231_10kimg002.gif GRAPHIC 8155
15 img1.jpg GRAPHIC 83437
  Complete submission text file 0001437749-14-004302.txt   9858330

Data Files

Seq Description Document Type Size
8 EXHIBIT 101.INS furx-20131231.xml EX-101.INS 1552993
9 EXHIBIT 101.SCH furx-20131231.xsd EX-101.SCH 70712
10 EXHIBIT 101.CAL furx-20131231_cal.xml EX-101.CAL 34278
11 EXHIBIT 101.DEF furx-20131231_def.xml EX-101.DEF 299359
12 EXHIBIT 101.LAB furx-20131231_lab.xml EX-101.LAB 472403
13 EXHIBIT 101.PRE furx-20131231_pre.xml EX-101.PRE 298228
Mailing Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560
Business Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560 919-456-7800
Furiex Pharmaceuticals, Inc. (Filer) CIK: 0001484478 (see all company filings)

EIN.: 271197863 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34641 | Film No.: 14696217
SIC: 2834 Pharmaceutical Preparations